[ET Net News Agency, 3 August 2026] HANSOH PHARMA (03692) fell 3% to HK$31.2.
It hits an intra-day low of HK$31.2, dipping below the 50-D SMA of HK$31.243, and an intra-day high of HK$32.18. The total shares traded was 3.26 million, with a value of HK$104.31m. The active buy/sell ratio is 48:52, with net selling turnover of HK$1.33m. OPTIVER TRADING HK accounts for greatest net responsive buying turnover of HK$1.47m, with volume weighted average price of HK$31.437. UBS accounts for greatest net responsive selling turnover of HK$2.22m, with volume weighted average price of HK$31.745. The stock has fallen a combined 6.9% over the past 3 consecutive trading days.
The Hang Seng Index now rose 89 points, or 0.3% to 25,973; the Hang Seng China Enterprises Index now rose 22 points, or 0.3% to 8,634.
Basic Information| Nominal | 31.200 | % Chg | -3.05% |
| High | 32.180 | Low | 31.200 |
| Shares Tr | 3.26m | Turnover | 104.31m |
| 10-D SMA | 32.410 | %H.V | 36.778 |
| 20-D SMA | 32.389 | VWAP | 32.005 |
| 50-D SMA | 31.243 | RSI14 | 44.675 |
Status: Dipping below the 50-D SMA, active buy/sell ratio is 48:52, with net selling turnover of HK$1.33m, falling a combined 6.9% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 31.200 | -3.05 |
| SIHUAN PHARM (00460) | 0.900 | Unchanged |
| GRAND PHARMA (00512) | 5.075 | -1.65 |
| SBP GROUP (01177) | 4.940 | -1.79 |
| HENGRUI PHARMA (01276) | 56.350 | -1.31 |
| LIVZON PHARMA (01513) | 26.300 | +1.31 |
| LUYE PHARMA (02186) | 2.035 | +0.25 |
| FOSUN PHARMA (02196) | 16.440 | +0.12 |
| UNI HEALTH (02211) | 0.740 | +8.82 |
| CHINARES PHARMA (03320) | 4.865 | +0.31 |
(ed)
